T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter

Name of the Condition

• Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter

Summary

This code describes poisoning resulting from assault involving cardiac-stimulant glycosides or drugs with similar actions, classified as a subsequent encounter. Cardiac-stimulant glycosides, such as digoxin, are used to treat heart conditions like atrial fibrillation and heart failure. The "assault" designation indicates intentional harm by another party, and "subsequent encounter" refers to care during the recovery phase after the initial incident. Clinical management focuses on addressing both the toxic effects and any ongoing sequelae.

Causes

Poisoning in this context results from intentional administration of cardiac-stimulant glycosides or similar drugs by another individual with the intent to cause harm. This may involve forced ingestion, injection, or other means of exposure. The assault scenario distinguishes it from accidental or self-inflicted poisonings, requiring documentation of the external cause.

Risk Factors

• Proximity to individuals with access to cardiac-stimulant glycosides (e.g., healthcare settings or homes with prescribed medications).
• Situations involving conflict or violence where intentional harm is possible.
• Lack of safeguards to prevent unauthorized access to these substances.

Symptoms

• Nausea, vomiting, or abdominal pain.
• Irregular heart rhythms (arrhythmias).
• Dizziness or fainting.
• Visual disturbances (e.g., blurred vision, yellow-green halos around lights).
• Weakness or fatigue.

Diagnosis

Diagnosis involves a patient history to identify potential exposure, physical examination to assess symptoms, and laboratory tests to detect glycoside levels. Documentation of the assault and subsequent encounter status is critical. Electrocardiograms (ECGs) may be used to evaluate cardiac effects, and toxicology screens can confirm the presence of the substance.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and supporting recovery. This may include administering antidotes (e.g., digoxin-specific antibody fragments), correcting electrolyte imbalances, and monitoring cardiac function. Psychological support and safety measures are also important given the assault context.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of treatment, and individual health factors. Subsequent encounters involve ongoing care to address residual effects or complications. Follow-up may include cardiac monitoring, medication adjustments, and referrals to mental health or social services as needed.

Complications

• Persistent arrhythmias or heart failure.
• Kidney damage from toxin exposure.
• Neurological effects, such as confusion or seizures.
• Psychological trauma related to the assault.

Lifestyle & Prevention

Prevention involves securing medications to prevent unauthorized access and addressing situations where assault risk is elevated. For survivors, support services and safety planning may reduce future risk. Healthcare providers should document all relevant details to guide ongoing care.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, especially after suspected exposure. Ongoing care is necessary for subsequent encounters to manage complications and support recovery.

Tips for Medical Coders

Use this code for poisoning by cardiac-stimulant glycosides or similar drugs due to assault, with "subsequent encounter" indicating care after the initial event. Document the assault context and ensure the encounter aligns with the recovery phase. Verify that the substance and intent are clearly recorded to support accurate coding.